The expression of ferritin, lactoferrin, transferrin receptor and solute carrier family 11A1 in the host response to BCG-vaccination and Mycobacterium tuberculosis challenge

Highlights ► Splenocytes from BCG and naïve guinea pigs were used to study ferritin levels. ► Ferritin was suppressed in vaccine-derived cells after PPD stimulation. ► TNFα and NO were involved in ferritin suppression. ► Microarray revealed suppression of further iron-related genes after M. tubercul...

Full description

Saved in:
Bibliographic Details
Published in:Vaccine 2012-05, Vol.30 (21), p.3159-3168
Main Authors: Thom, R.E, Elmore, M.J, Williams, A, Andrews, S.C, Drobniewski, F, Marsh, P.D, Tree, J.A
Format: Article
Language:English
Subjects:
Allergy and Immunology
Animals
BCG
BCG Vaccine - immunology
Biomarkers
Cation Transport Proteins - biosynthesis
Cofactors
Ferritin
Ferritins - biosynthesis
Gene expression
Gene Expression Profiling
gene expression regulation
genes
Guinea pig
Guinea Pigs
Immune response
Infection
Inflammation
Iron
Iron - metabolism
lactoferrin
Lactoferrin - biosynthesis
messenger RNA
Metabolism
Microarray Analysis
microarray technology
Mycobacterium tuberculosis
Mycobacterium tuberculosis - immunology
Nitric oxide
Real-Time Polymerase Chain Reaction
Receptors, Transferrin - biosynthesis
reverse transcription
Solutes
Splenocytes
transferrin
Transferrin receptors
Tuberculin
Tuberculosis
Tuberculosis - prevention & control
Tumor necrosis factor- alpha
Vaccination
vaccines
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Highlights ► Splenocytes from BCG and naïve guinea pigs were used to study ferritin levels. ► Ferritin was suppressed in vaccine-derived cells after PPD stimulation. ► TNFα and NO were involved in ferritin suppression. ► Microarray revealed suppression of further iron-related genes after M. tuberculosis infection. ► The regulation of iron is an important mechanism induced by BCG-vaccination.
ISSN:0264-410X
1873-2518
DOI:10.1016/j.vaccine.2012.03.008